Document is current

Article History

Received: 4 September 2017

Accepted: 23 February 2018

First Online: 9 March 2018

Ethics approval and consent to participate

: The study was approved by the Danish Data Protection Agency (j.no: 1–16–02-495-15) and by the Danish Health Authorities (j.no: 3–3013-1407/1). Furthermore, the study achieved clearance at the Central Denmark Region Committees on Health Research Ethics (j.no: 1–10–72-259-15). The included women were informed that if they returned their self-sample they thereby expressed their consent to participate in the study.

: Not applicable.

: Axlab, the Danish manufacturer of Evalyn® Brush, and Roche, the manufacturer of the Cobas® 4800 HPV DNA assay, provided self-sampling devices and test kits for the study. According to the contract between the manufacturers and the Department of Public Health Programmes, Randers Regional Hospital, Axlab and Roche had no influence on the scientific process and no editorial rights pertaining to this manuscript. The authors retained the right to submit the manuscript. None of the authors were compensated for their work on this study, have any shares in the manufacturers’ companies, or received bonuses from any of the manufacturers. All authors declare no conflicts of interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.